The EU's medicines regulator said on Wednesday that blood clots should be listed as a rare side effect of the AstraZeneca vaccine but the benefits of the jab continue to outweigh risks, as several countries battle fresh virus surges amid vaccine shortfalls. A number of nations have suspended the use of AstraZeneca's vaccine for younger populations after it was earlier banned outright in several places over blood clot scares.from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3dFT0nX
Post a Comment